SONN (Sonnet BioTherapeutics Holdings) FCF Margin %: 0.00% (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SONN Sonnet BioTherapeutics Holdings Inc SONN
28 GF Score
Price $1.26
View Full Analysis

What is Sonnet BioTherapeutics Holdings FCF Margin %?

Sonnet BioTherapeutics Holdings SONN 28 FCF Margin % is 0.00% as of Jun. 2025. GuruFocus rates SONN with a GF Score™ of 28/100.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Sonnet BioTherapeutics Holdings's Free Cash Flow for the three months ended in Jun. 2025 was $-1.76 Mil. Sonnet BioTherapeutics Holdings's Revenue for the three months ended in Jun. 2025 was $0.00 Mil. Therefore, Sonnet BioTherapeutics Holdings's FCF Margin % for the quarter that ended in Jun. 2025 was 0.00%.

As of today, Sonnet BioTherapeutics Holdings's current FCF Yield % is 0.00%.

The historical rank and industry rank for Sonnet BioTherapeutics Holdings's FCF Margin % or its related term are showing as below:

SONN' s FCF Margin % Range Over the Past 10 Years
Min: -1031   Med: 0   Max: 0
Current: -1031

SONN's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -81.28 vs SONN: -1031.00

Sonnet BioTherapeutics Holdings FCF Margin % Related Terms

Sonnet BioTherapeutics Holdings FCF Margin % Historical Data

* Premium members only.

The historical data trend for Sonnet BioTherapeutics Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sonnet BioTherapeutics Holdings FCF Margin % Chart

Sonnet BioTherapeutics Holdings Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
FCF Margin %
Get a 7-Day Free Trial 0.00 -4,660.33 -8,166.86 -14,719.59 -45,368.42

Sonnet BioTherapeutics Holdings Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -291.00 0.00 0.00

SONN vs CING, BOLD, DARE: FCF Margin % Comparison

For the Biotechnology subindustry, Sonnet BioTherapeutics Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sonnet BioTherapeutics Holdings FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sonnet BioTherapeutics Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Sonnet BioTherapeutics Holdings's FCF Margin % falls into.


SONN
28GF Score
Sonnet BioTherapeutics Holdings Inc SONN
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sonnet BioTherapeutics Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Sonnet BioTherapeutics Holdings's FCF Margin for the fiscal year that ended in Sep. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Sep. 2024 )/Revenue (A: Sep. 2024 )
=-8.62/0.019
=-45,368.42 %

Sonnet BioTherapeutics Holdings's FCF Margin for the quarter that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2025 )/Revenue (Q: Jun. 2025 )
=-1.759/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Sonnet BioTherapeutics Holdings (SONN) has a FCF Margin % of 0.00% as of Jun. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sonnet BioTherapeutics Holdings and its competitors.
Is Sonnet BioTherapeutics Holdings' FCF Margin % too high?
Sonnet BioTherapeutics Holdings' current FCF Margin % is 0.00%. Overall, Sonnet BioTherapeutics Holdings has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Sonnet BioTherapeutics Holdings' FCF Margin % compare to CING and BOLD?
Sonnet BioTherapeutics Holdings' FCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sonnet BioTherapeutics Holdings and its competitors. Sonnet BioTherapeutics Holdings's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonnet BioTherapeutics Holdings stock overvalued right now?
Sonnet BioTherapeutics Holdings (SONN) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Sonnet BioTherapeutics Holdings' overall GF Score™ is 28/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Sonnet BioTherapeutics Holdings (SONN), the current FCF Margin % is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sonnet BioTherapeutics Holdings Business Description

Address 100 Overlook Center, Suite 102, Princeton, NJ, USA, 08540
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
28GF Score

Get the complete analysis for SONN

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.26
Price